EUVIMEDEUVIMED entdecken
Crossref

Effectiveness of diphenyl diselenide against experimental sporotrichosis caused by Sporothrix brasiliensis

Lívia Silveira Munhoz iD, Vanice Rodrigues Poester iD, Jéssica Louise Benelli iD, Aryse Martins Melo iD, Mariana Rodrigues Trápaga iD, Cristina Wayne Nogueira, Gilson Zeni, Mariana Martins Flores, David A Stevens, Melissa Orzechowski Xavier iD

Medical Mycology · 03.04.2023 · 61 (4)

DOI: 10.1093/mmy/myad035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Mycology, online erschienen am 28.03.2023. Verfasst von Lívia Silveira Munhoz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Programa de Pós-graduação em Ciências da Saúde, Faculdade de Medicina (FAMED), Universidade Federal do Rio Grande (FURG), Rio Grande city, Rio Grande…. Hauptthemen laut MEDLINE: Sporotrichosis, Sporothrix, Cat Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: CNPq, FAPERGS, CAPES.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diphenyl diselenide (PhSe)2 is a stable organoselenium compound with promising in vitro antifungal activity against several fungi, including Sporothrix brasiliensis. This species is associated with feline and zoonotic sporotrichosis, an emergent mycosis in Latin America. We evaluated the activity of (PhSe)2, alone and in association with itraconazole, in the treatment of sporotrichosis caused by S. brasiliensis, in a murine model. Sixty mice were subcutaneously infected with S. brasiliensis in the footpad and treated by gavage for 30 consecutive days. The six treatment groups received: no active treatment, itraconazole (50 mg/kg), (PhSe)2 at 1, 5, and 10 mg/kg dosages, or itraconazole (50 mg/kg) + (PhSe)2 1 mg/kg, once a day, starting seven days post-inoculation. A significant reduction in the fungal burden of internal organs was achieved in the groups treated with (PhSe)2 1 mg/kg or itraconazole alone in comparison with the untreated group. Higher dosages (5 and 10 mg/kg) of (PhSe)2 increased the clinical manifestation of sporotrichosis and mortality rate. Treatment with both itraconazole and (PhSe)2 1 mg/kg was better than their activities alone (P < .001). This is the first demonstration of the potential use of (PhSe)2, alone or with the present drug of choice, in the treatment of sporotrichosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SporotrichosisSporothrixCat DiseasesAnimalsCatsMiceItraconazoleMicrobial Sensitivity TestsAntifungal AgentsBenzene DerivativesOrganoselenium Compounds

Stichwörter der Autor:innen

in vivo modelantifungal treatmentitraconazoleorganoselenium compoundsubcutaneous mycoses

Substanzen

ItraconazoleAntifungal AgentsdiphenyldiselenideBenzene DerivativesOrganoselenium Compounds

Autor:innen und Institutionen

  • Programa de Pós-graduação em Ciências da Saúde, Faculdade de Medicina (FAMED), Universidade Federal do Rio Grande (FURG), Rio Grande city, Rio Grande do Sul state, 96203-900, Brazil.
  • Universidade Federal de Santa Maria (UFSM), Santa Maria city, Rio Grande do Sul state, 97105-900, Brazil.
  • Hospital Universitário Dr. Miguel Riet Corrêa Jr. (HU-FURG), vinculado à Empresa Brasileira de Serviços Hospitalares (EBSERH), Rio Grande city, Rio Grande do Sul state, 96200-190, Brazil.
  • Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisboa, 1600-609, Portugal.
  • California Institute for Medical Research, San Jose, California 95128, USA.
  • Division of Infectious Diseases and Geographic Medicine, Stanford University Medical School, Stanford, California 94305, USA.

ORCID-Profile: Lívia Silveira Munhoz, Vanice Rodrigues Poester, Jéssica Louise Benelli, Aryse Martins Melo, Mariana Rodrigues Trápaga, Melissa Orzechowski Xavier

Förderung

  • CNPq
  • FAPERGS
  • CAPES

Zitieren

APA

Munhoz, L. S., Poester, V. R., Benelli, J. L., Melo, A. M., Trápaga, M. R., Nogueira, C. W., Zeni, G., Flores, M. M., Stevens, D. A., & Xavier, M. O. (2023). Effectiveness of diphenyl diselenide against experimental sporotrichosis caused by Sporothrix brasiliensis. Medical Mycology, 61(4). https://doi.org/10.1093/mmy/myad035

Vancouver

Munhoz LS, Poester VR, Benelli JL, Melo AM, Trápaga MR, Nogueira CW, et al. Effectiveness of diphenyl diselenide against experimental sporotrichosis caused by Sporothrix brasiliensis. Medical Mycology. 2023;61(4). doi:10.1093/mmy/myad035

BibTeX
@article{Munhoz2023,
  author = {Munhoz, Lívia Silveira and Poester, Vanice Rodrigues and Benelli, Jéssica Louise and Melo, Aryse Martins and Trápaga, Mariana Rodrigues and Nogueira, Cristina Wayne and Zeni, Gilson and Flores, Mariana Martins and Stevens, David A and Xavier, Melissa Orzechowski},
  title = {Effectiveness of diphenyl diselenide against experimental sporotrichosis caused by Sporothrix brasiliensis},
  journal = {Medical Mycology},
  year = {2023},
  volume = {61},
  number = {4},
  doi = {10.1093/mmy/myad035}
}
Kostenlos starten →